Literature DB >> 20533913

22q11 deletion syndrome - the meaning of a diagnosis. A qualitative study on parental perspectives.

U Hallberg1, S Oskarsdóttir, G Klingberg.   

Abstract

BACKGROUND: The 22q11 deletion syndrome (22q11DS) is one of the most common multiple anomaly syndromes, with an incidence of approximately one per 4000 newborns. Although a patient may have several not too severe symptoms, the cumulative effect may be substantial disability. The aim of this study was to explore and describe parents' experiences of the diagnostic process and of being parents of a child with 22q11DS.
METHODS: Open, tape-recorded interviews were carried out with 12 parents. The interviews were analysed in accordance with classical grounded theory.
RESULTS: The analysis show that parents describe the disclosure of their child's medical diagnosis as two-sided, ambivalence between relief and sorrow, and the differences between these two aspects were related to the age of the child at time of diagnosis as well as to the problems and symptoms that had led to the diagnosis. Different strategies for handling this ambivalence are presented in the categories.
CONCLUSIONS: Our conclusions are that information must be individually tailored, and there is no standard format for how to describe the syndrome to the parents. After disclosure, scheduled appointments for follow-up on diagnosis-related information is essential.

Entities:  

Mesh:

Year:  2010        PMID: 20533913     DOI: 10.1111/j.1365-2214.2010.01108.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  11 in total

1.  Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome.

Authors:  G Costain; E W C Chow; P N Ray; A S Bassett
Journal:  J Intellect Disabil Res       Date:  2011-12-06

2.  Parents' Experience with Pediatric Microarray: Transferrable Lessons in the Era of Genomic Counseling.

Authors:  R Z Hayeems; R Babul-Hirji; N Hoang; R Weksberg; C Shuman
Journal:  J Genet Couns       Date:  2015-08-12       Impact factor: 2.537

3.  A tale worth telling: the impact of the diagnosis experience on disclosure of genetic disorders.

Authors:  J Goodwin; K Schoch; V Shashi; S R Hooper; O Morad; M Zalevsky; D Gothelf; L E Campbell
Journal:  J Intellect Disabil Res       Date:  2014-07-25

4.  Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome.

Authors:  D J Karas; G Costain; E W C Chow; A S Bassett
Journal:  J Intellect Disabil Res       Date:  2012-10-29

5.  Parental stress and adjustment in the context of rare genetic syndromes: A scoping review.

Authors:  Jacqueline Fitzgerald; Louise Gallagher
Journal:  J Intellect Disabil       Date:  2021-04-19

6.  The psychosocial impact of 22q11 deletion syndrome on patients and families: A systematic review.

Authors:  Oanh Kieu Vo; Alisdair McNeill; Katharina Sophie Vogt
Journal:  Am J Med Genet A       Date:  2018-03-25       Impact factor: 2.802

7.  Mind-Mindedness and Stress in Parents of Children with Developmental Disorders.

Authors:  Fionnuala Larkin; Marianna E Hayiou-Thomas; Zaynah Arshad; Matthew Leonard; Frances J Williams; Nicoletta Katseniou; Rania N Malouta; Charlotte R P Marshall; Maria Diamantopoulou; Etonia Tang; Sneha Mani; Elizabeth Meins
Journal:  J Autism Dev Disord       Date:  2021-02

8.  Discussing the psychiatric manifestations of 22q11.2 deletion syndrome: an exploration of clinical practice among medical geneticists.

Authors:  Emily Morris; Angela Inglis; Jan Friedman; Jehannine Austin
Journal:  Genet Med       Date:  2013-04-11       Impact factor: 8.822

9.  Caregiver Perspectives on a Child's Diagnosis of 3q29 Deletion: "We Can't Just Wish This Thing Away".

Authors:  Megan R Glassford; Ryan H Purcell; Sarah Pass; Melissa M Murphy; Gary J Bassell; Jennifer G Mulle
Journal:  J Dev Behav Pediatr       Date:  2022 Feb-Mar 01       Impact factor: 2.225

10.  Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.

Authors:  Lotte Krabbenborg; L E L M Vissers; J Schieving; T Kleefstra; E J Kamsteeg; J A Veltman; M A Willemsen; S Van der Burg
Journal:  J Genet Couns       Date:  2016-04-20       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.